Given that neddylation inhibition promotes glutamine metabolism by causing ASCT2 accumulation via inactivation of CRL3SPOP, we next determined whether the newly identified ASCT2 inhibitor, V-930218, would sensitize breast cancer cells to MLN4924. This evidence concerns the gene SLC1A5 and breast carcinoma.